Pharmafile Logo
Pharmafocus logo
Advanced Search

Pfizer

Showing 15 posts of 894 posts found.

It's in your hands website image

Pfizer launches new website for Dupuytren’s disease

June 12, 2012
Medical Communications, Sales and Marketing Dupuytren's disease, Pfizer, Xiapex, it is in your hands

Pfizer has released a new interactive video and website aimed at helping people with Dupuytren’s disease, a debilitating hand condition. …

News
Pfizer image

Pfizer to create standalone animal health business

June 8, 2012
Sales and Marketing Ian Read, Pfizer, Zoetis, nestle, standalone

Pfizer has said it is setting up a new standalone company out of its animal health division. This means it …

News

Lipitor fallout prompts Pfizer to cut Irish workforce

June 7, 2012
Manufacturing and Production Amgen, Ireland, Lipitor, Pfizer, cuts, patent loss

Falling demand for blockbuster cholesterol drug Lipitor has prompted Pfizer to cut staff levels at two manufacturing facilities in Ireland. …

News

Pfizer appoints two senior roles

May 24, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Pfizer, Read

Pfizer has named Olivier Brandicourt as president and general manager of its Emerging Markets and Established Products Business Units, and …

Appointment

Plavix loses US patent protection

May 18, 2012
Sales and Marketing BMS, FDA, Lipitor, Pfizer, Plavix, Sanofi

Sanofi and Bristol-Myers Squibb’s blood thinner Plavix has lost its patent protection in the US.  The drug, which made $6.6 …

News
NICE image

NICE comes out fighting against appraisal delays story

May 17, 2012
Sales and Marketing Daily Mail, Dillon, NHS, NICE, Pfizer, Victrelis

NICE has criticised a report that says the watchdog has taken up to nine years to appraise certain drugs.   The …

News
Nexavar image

Torisel fails in head-to-head study with Nexavar

May 16, 2012
Research and Development, Sales and Marketing Bayer, Nexavar, Pfizer, Torisel, inlyta, rcc

Pfizer’s kidney cancer drug Torisel has failed to best Bayer’s Nexavar in a head-to-head trial.  The Phase III study was …

News

Pfizer’s RA drug on course for approval

May 10, 2012
Sales and Marketing Humira, JAK inhibitor, Pfizer, RA, rheumatoid arthritis, tofacitinib

An FDA advisory committee has recommended for approval Pfizer’s new rheumatoid arthritis treatment tofacitinib.The Arthritis Advisory Committee voted 8-2 to …

News

Novo Nordisk appoints ex-Pfizer head

May 10, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, Pfizer, Robert Clark, regulatory affairs

Robert Clark will be joining Novo Nordisk as vice president, regulatory affairs. Clark will lead Novo Nordisk’s US regulatory team, …

Appointment
Pfizer picture

Lyrica fails in diabetes and HIV pain

May 9, 2012
Sales and Marketing Lyrica, Pfizer, neuropathic pain, pain

Two separate Phase III trials of Lyrica have failed to show benefits in treating nerve pain – one in HIV …

News

Pfizer releases new data for Pristiq

May 9, 2012
Research and Development, Sales and Marketing Effexor, MDD, Pfizer, Pristiq, antidepressant

Pfizer has released positive data for its established antidepressant Pristiq, as it hopes to extend the use of the drug.  …

News

Teva launches first generic Lipitor in UK

May 8, 2012
Sales and Marketing Lipitor, NHS, Pfizer, Teva, atorvastatin

Teva has launched the first generic Lipitor in the UK on the day the drug loses its patent protection.  The …

News
Shell oil website

Roche and Novartis have best websites

May 3, 2012
Medical Communications Bowen Craggs & Co, Novartis, Pfizer, Roche, Shell, digital, web

A new survey of leading international companies has found Roche and Novartis have the best websites in the pharma sector.  …

News

Pfizer enters Gaucher disease market

May 3, 2012
Sales and Marketing Cerezyme, Elelyso, Gaucher, Genzyme, Pfizer, Shire, Vpriv

Pfizer has gained FDA approval for its new Gaucher disease drug Elelyso.  Elelyso (taliglucerase alfa) is an enzyme replacement therapy …

News
Ian Read

Lipitor losses hit Pfizer

May 2, 2012
Sales and Marketing Alzheimer's, Lipitor, Pfizer, patent expiry

Lipitor’s US patent expiry has inflicted heavy damage on Pfizer’s revenues, with global sales down 7% in the first three …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026